Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "RAG"

2405 News Found

Raay Neo Pharma launches operations to expand access to quality healthcare across India
News | April 27, 2026

Raay Neo Pharma launches operations to expand access to quality healthcare across India

Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies


Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
Policy | April 25, 2026

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India


NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
Public Health | April 25, 2026

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem

Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms


Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
Supply Chain | April 25, 2026

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance


Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1
News | April 25, 2026

Siegfried locks in major CDMO expansion deal as US & Australia sites join global network from May 1

The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network


New genomics clinic by Fortis Hospitals targets early disease detection
Healthcare | April 24, 2026

New genomics clinic by Fortis Hospitals targets early disease detection

New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


Johnson & Johnson wins EU nod for next-gen surgical stapler
Medical Device | April 24, 2026

Johnson & Johnson wins EU nod for next-gen surgical stapler

The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union